Header Logo

Connection

Mark Schmidt to Hepatitis C, Chronic

Back to Details
This is a "connection" page, showing publications Mark Schmidt has written about Hepatitis C, Chronic.
Mark Schmidt
Connection Strength
3.360
Hepatitis C, Chronic
  1. Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis?C and Cirrhosis. Adv Ther. 2024 Feb; 41(2):744-758.
    View in: PubMed
    Score: 0.221
  2. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat. 2023 09; 30(9):746-755.
    View in: PubMed
    Score: 0.213
  3. The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017. Clin Infect Dis. 2021 09 07; 73(5):891-894.
    View in: PubMed
    Score: 0.188
  4. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol. 2021 01; 55(1):77-83.
    View in: PubMed
    Score: 0.179
  5. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. J Viral Hepat. 2019 10; 26(10):1210-1217.
    View in: PubMed
    Score: 0.162
  6. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
    View in: PubMed
    Score: 0.157
  7. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Aliment Pharmacol Ther. 2019 03; 49(5):599-608.
    View in: PubMed
    Score: 0.157
  8. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018 06; 32(2):253-268.
    View in: PubMed
    Score: 0.150
  9. A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C. Dig Dis Sci. 2017 11; 62(11):3221-3234.
    View in: PubMed
    Score: 0.143
  10. Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution. Dig Dis Sci. 2017 10; 62(10):2704-2712.
    View in: PubMed
    Score: 0.143
  11. Changing trends in complications of chronic hepatitis C. Liver Int. 2018 02; 38(2):239-247.
    View in: PubMed
    Score: 0.141
  12. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study. Dig Dis Sci. 2016 12; 61(12):3469-3477.
    View in: PubMed
    Score: 0.132
  13. Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Dig Dis Sci. 2016 07; 61(7):2087-93.
    View in: PubMed
    Score: 0.130
  14. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma. J Viral Hepat. 2016 09; 23(9):718-29.
    View in: PubMed
    Score: 0.129
  15. Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection. Clin Gastroenterol Hepatol. 2016 07; 14(7):1044-1055.e3.
    View in: PubMed
    Score: 0.127
  16. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus. Clin Infect Dis. 2016 Feb 01; 62(3):289-297.
    View in: PubMed
    Score: 0.125
  17. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study. Am J Gastroenterol. 2015 Aug; 110(8):1169-77; quiz 1178.
    View in: PubMed
    Score: 0.123
  18. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention. Hepatology. 2015 May; 61(5):1479-84.
    View in: PubMed
    Score: 0.120
  19. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology. 2015 Mar; 61(3):802-11.
    View in: PubMed
    Score: 0.119
  20. Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort. Clin Infect Dis. 2015 Feb 15; 60(4):514-22.
    View in: PubMed
    Score: 0.117
  21. Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS). J Community Health. 2014 Oct; 39(5):914-21.
    View in: PubMed
    Score: 0.116
  22. Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification. Dig Dis Sci. 2014 Dec; 59(12):3053-61.
    View in: PubMed
    Score: 0.115
  23. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014 Dec; 21(12):930-7.
    View in: PubMed
    Score: 0.111
  24. Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunities. Am J Manag Care. 2019 08; 25(8):369-374.
    View in: PubMed
    Score: 0.041

© 2024 Kaiser Permanente